Author

Dung‐Tsa Chen

Moffitt Cancer Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1 Assay:proteomics· 1

Frequent Co-Authors

Andriy MarusykiD· 1 shared Bina DesaiiD· 1 shared Bruna PelliniiD· 1 shared Denise KalosiD· 1 shared Eric B. HauraiD· 1 shared Gina S. Nazario· 1 shared Hilal ÖzakıncıiD· 1 shared Hitendra Singh SolankiiD· 1 shared

Activity by Year

2024-2024 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Andriy MarusykORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Trastuzumab deruxtecan combination strongly enhances responses and overcomes sotorasib resistance in KRASG12C-mutant NSCLC

Hilal Özakıncı, Bina Desai, Denise Kalos, Dung‐Tsa Chen, Menkara Henry, Hitendra Singh Solanki, Theresa A. Boyle, Humberto E. Trejo Bittar, Gina S. Nazario, Eric B. Haura, Andriy Marusyk, Bruna Pellini

This study shows that combining trastuzumab deruxtecan with sotorasib improves responses in KRASG12C-mutant NSCLC and overcomes resistance, but HER2 expression levels influence treatment effectiveness.

bioRxiv · Dec 17, 2024 · PreprintCancer Biology